Skip to content

CMSD

Active
Private limited companyfounded 2022active for 3 yearsRue des Potiers 326, 6717 Attert, BelgiumKBO/BCE: BE 0794.763.758
Summary

CMSD has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €35,559 and a net result of €17,269. Its solvency ranks better than 31% of 19,741 sector peers (NACE 86, financial year 2024). The computed 12-month bankruptcy probability is 0.4% (very low).

Overview

Activity
General medical practice
NACE 86210
1 site
Size
€77,321total assets 2024
Equity
€35,559
Profit
€17,269
Turnover not published (micro format)
Financial health
56 Fair Checked score 2024
Bankruptcy probabilitywithin 12 months
0.4%
Structure
Accounts 83 days overdue0 of 1 deed read
Why 56raises riskCapped at 59: a confirmed filing findingFigures for financial year 2024 (filed 30-10-2025)1 financial year not filed after the legal deadline; latest accounts 91 days late; 2 of the last 3 latelowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.87, cash €47,961Show the evidence

Checked score

Score 2024
56 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 61% of its sector peers (NACE 86, micro)
A confirmed filing finding caps the score at 59. Every signal that counts is listed under Signals.
Financial strength · tick = 2023
Strong
Solvency 71-15
equity 46.0% of total assets
Liquidity 80-13
short-term debt 41.3% · cash 62.0%
Profitability 97-3
return on assets 22.3%
Bankruptcy probability, 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%

About 4 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,098 companies, NACE 86, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.2%▲ +0.1 percentage points vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.5%▲ +0.3 percentage points vs 09-2025highest value 11-2025: 0.1%▼ -0.4 percentage points vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: < 0.1%▼ -0.1 percentage points vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: 0.1%▲ +0.1 percentage points vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.2%▲ +0.1 percentage points vs 08-2026 10-2026: 0.4%▲ +0.2 percentage points vs 09-2026
Credit of up to €1,500 on 30-day terms, only on tighter conditions: an expected filing is missing beyond Checked's processing allowance
Liquidity ample (current ratio 1.87, compared with 3.31 in 2023, above the usual 1.5; short-term debt: 41.3% and cash: 62% of total assets), but 54% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 37% on solvency, 62% on liquidity, 56% on profitability and 88% on growth.

The bankruptcy probability was computed on 21-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises risk
raises risk · Figures for financial year 2024 (filed 30-10-2025)
NBB · annual accounts
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · 1 financial year not filed after the legal deadline; latest accounts 91 days late; 2 of the last 3 late
NBB · filings
lowers risk · Liquidity: current ratio 1.87, cash €47,961
NBB · annual accounts
raises risk · Annual accounts not filed
The financial year that closed on 31-12-2025 was due at the National Bank by 31-07-2026. Nothing is on record, 83 days later.
NBB · 2 filings
Position against the passed deadline
31-12-2025 year end31-07-2026 deadline22-10-2026 today
raises risk · Filed more than 90 days late
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-10-2025, 91 days past the deadline. Measured on financial year 2023: of the companies more than 90 days late, 5.61% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers.
NBB · 2 filings
Deviation from the deadline
2025
not filed
2024
91 days late
2023
91 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 2 accounts on average 91 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2022.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2024 · micro…
  2. Annual accounts filedfinancial year 2023 · micro…

Financials · financial year 2024, micro format

2025 annual accounts not yet filed, deadline passed on 31 July 2026 Financial year closed on 31 December 2025; filing due at the latest 7 months after the close (Companies Code art. 3:10). Source: NBB filings, as of 22 October 2026.

Equity
€35,559▲ 85.7%
2023 · €19,150
Total assets
€77,321▲ 146%
2023 · €31,486
Net result
€17,269▲ 88.7%
2023 · €9,150
Working capital
€27,815▲ 83.1%
2023 · €15,187
Trend over the years

2023 to 2024, 2 financial years

The operating result rises in 2024; 2024 is 75% above 2023.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€22,264 2024 Net result€17,269 2024

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line20232024
Operating result€12,709-€22,264▲ 75.2%
Net result€9,150below the sector's middle half-€17,269below the sector's middle half▲ 88.7%
Equity€19,150below the sector's middle half-€35,559below the sector's middle half▲ 85.7%
Total assets€31,486below the sector's middle half-€77,321below the sector's middle half▲ 146%
Debt€12,336-€41,762▲ 239%
Working capital€15,187below the sector's middle half-€27,815within the sector's middle half▲ 83.1%
Solvency60.8%within the sector's middle half-46.0%within the sector's middle half▼ 14.8pp
Current ratio3.31within the sector's middle half-1.87within the sector's middle half▼ 1.44
Return on assets (ROA)29.1%within the sector's middle half-22.3%within the sector's middle half▼ 6.7pp
above within below the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the micro format does not require them.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €76,414
Fixed assets €16,650 ▲ 112%
Current assets €59,764 ▲ 175%
Equity and liabilities €77,321
Equity €35,559 ▲ 85.7%
Debt €41,762 ▲ 239%
Debt's share of the balance-sheet total rises from 39.2% to 54.0%. Equity and debt are higher.
Key figures and ratios
2024 value · change against 2023
EBITDA
€27,016▲
2023 · €16,447
Cash flow
€22,020▲
2023 · €12,888
Debt to equity
1.17▲
2023 · 0.64
ROE
48.6%▲
2023 · 47.8%
Interest coverage
71.36▼
2023 · over 100
Debt ≤ 1 year
€31,949▲
2023 · €6,574
Debt > 1 year
€4,814
Income taxes
€4,763▲
2023 · €3,512
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 39,278 companies that looked in July 2024 the way this one looks now, 1.8% went bankrupt within 24 months and 95.8% are still going.

  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
1.8% went bankrupt
2.3% stopped otherwise
95.8% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 0.4% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,473 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 39,278 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2024 against 2023 · 46 lines
Balance sheet Code20232024
Assets
Total assets20/58€31,486€77,321▲
Formation expenses20€1,859€907▼
Fixed assets21/28€7,866€16,650▲
Intangible fixed assets21€791€591▼
Tangible fixed assets22/27€7,075€16,060▲
Plant, machinery and equipment23€863€421▼
Furniture and vehicles24€6,212€15,638▲
Current assets29/58€21,761€59,764▲
Amounts receivable within one year40/41€1,349€2,619▲
Other amounts receivable41€1,349€2,619▲
Cash at bank and in hand54/58€14,223€47,961▲
Deferred charges and accrued income490/1€6,189€9,183▲
Equity and liabilities
Total equity and liabilities10/49€31,486€77,321▲
Equity10/15€19,150€35,559▲
Contributions10/11€10,000€10,000=
Reserves13€9,150€9,150=
Distributable reserves133€9,150€9,150=
Profit (loss) carried forward14€0€16,410▲
Amounts payable17/49€12,336€41,762▲
Amounts payable after more than one year17-€4,814
Financial debts170/4-€4,814
Amounts payable within one year42/48€6,574€31,949▲
Current portion of amounts payable after more than one year42-€6,238
Trade debts44€603€5,403▲
Suppliers440/4€603€5,403▲
Taxes, remuneration and social security45€5,971€19,449▲
Taxes450/3€5,971€19,449▲
Other amounts payable47/48€0€859▲
Accrued charges and deferred income492/3€5,762€4,999▼
Income statement Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3,738€4,751▲
Other operating charges640/8€1,376€1,224▼
Gross operating margin9900€17,823€28,239▲
Operating profit (loss)9901€12,709€22,264▲
Financial income75/76B€44€146▲
Recurring financial income75€44€146▲
Financial charges65/66B€91€379▲
Recurring financial charges65€91€379▲
Profit (loss) for the period before taxes9903€12,662€22,032▲
Income taxes67/77€3,512€4,763▲
Profit (loss) for the period9904€9,150€17,269▲
Profit (loss) for the period to be appropriated9905€9,150€17,269▲
Appropriation of the result
Profit (loss) to be appropriated9906€9,150€17,269▲
Transfer to equity691/2€9,150-
To other reserves6921€9,150-
Profit to be distributed694/7-€859
Return on contributions (dividend)694-€859

The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20232024Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3,738€4,751▲ 27.1%
Other operating charges640/8€1,376€1,224▼ 11.1%
Gross operating margin9900€17,823€28,239▲ 58.4%
Operating profit (loss)9901€12,709€22,264▲ 75.2%
Financial income75/76B€44€146▲ 233%
Recurring financial income75€44€146▲ 233%
Financial charges65/66B€91€379▲ 316%
Recurring financial charges65€91€379▲ 316%
Profit (loss) for the period before taxes9903€12,662€22,032▲ 74.0%
Income taxes67/77€3,512€4,763▲ 35.6%
Profit (loss) for the period9904€9,150€17,269▲ 88.7%
Profit (loss) for the period to be appropriated9905€9,150€17,269▲ 88.7%
Line20232024Change
Assets
Total assets20/58€31,486€77,321▲ 146%
Formation expenses20€1,859€907▼ 51.2%
Fixed assets21/28€7,866€16,650▲ 112%
Intangible fixed assets21€791€591▼ 25.3%
Tangible fixed assets22/27€7,075€16,060▲ 127%
Plant, machinery and equipment23€863€421▼ 51.2%
Furniture and vehicles24€6,212€15,638▲ 152%
Current assets29/58€21,761€59,764▲ 175%
Amounts receivable within one year40/41€1,349€2,619▲ 94.1%
Other amounts receivable41€1,349€2,619▲ 94.1%
Cash at bank and in hand54/58€14,223€47,961▲ 237%
Deferred charges and accrued income490/1€6,189€9,183▲ 48.4%
Equity and liabilities
Total equity and liabilities10/49€31,486€77,321▲ 146%
Equity10/15€19,150€35,559▲ 85.7%
Contributions10/11€10,000€10,000=
Reserves13€9,150€9,150=
Distributable reserves133€9,150€9,150=
Profit (loss) carried forward14€0€16,410-
Amounts payable17/49€12,336€41,762▲ 239%
Amounts payable after more than one year17-€4,814-
Financial debts170/4-€4,814-
Amounts payable within one year42/48€6,574€31,949▲ 386%
Current portion of amounts payable after more than one year42-€6,238-
Trade debts44€603€5,403▲ 796%
Suppliers440/4€603€5,403▲ 796%
Taxes, remuneration and social security45€5,971€19,449▲ 226%
Taxes450/3€5,971€19,449▲ 226%
Other amounts payable47/48€0€859-
Accrued charges and deferred income492/3€5,762€4,999▼ 13.2%
Line20232024Change
Profit (loss) for the period9904€9,150€17,269▲ 88.7%
+ Depreciation and write-downs630€3,738€4,751▲ 27.1%
Operating cash flow (approximation)€12,888€22,020▲ 70.9%
Investment in fixed assets (approximation)--€13,536-
Change in cash-€33,738-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (2)
Financial year Type Filed Reference
31-12-2024 micro format 30-10-2025 2025-00553422
31-12-2023 micro format 30-10-2024 2024-00521625

Similar companies · same sector, comparable size

Of the 9,148 active companies whose main activity is general medical practice (NACE 86210), figures are known for 6,432. 4,202 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
No directors read yet: 0 of 1 Gazette act processed. See the directors and other office holders in the KBO →

Owners and capital

Owners

No owners or capital events in the accounts and acts we read.

History

On 14 December 2022, CMSD was incorporated as a private limited company.1 The company has filed 2 sets of annual accounts, the latest for financial year 2024.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2024

Acts, filings and financial milestones

2025
30-10
NBB filing Annual accounts filed
financial year 2024 · micro format · 91 days late
2024
30-10
NBB filing Annual accounts filed
financial year 2023 · micro format · 91 days late
NBB filing
0 of 1 deed read
About the unread acts

We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded14-12-2022
Financial year end31-12
Activities, NACEBEL 2025
86210General medical practice
E-invoicing
Reachable via Peppol
Peppol ID 0208:0794763758
Registered 12-08-2026

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 21 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Attert · 1 establishment unit since 2022
registered office establishment The establishment unit on the map
Ground area
1,482 m²
Building footprint
230 m²
Building volume
550 m³
2 parcels, Wallonia · tallest building 8.7 m. Linked by address, not a title deed.
1 establishment unit
Rue des Potiers 326A, 6717 Attert
General medical practice
since 2022unit no. 2.343.181.092
2 parcels
Wallonia 2 (100%)
Cadastral parcel Region Area Buildings Height / floors
81003D0112/00D000 Wallonia 753 m² 1 · 79 m² 8.7 m · 2
81003D0109/00K000 Wallonia 729 m² 1 · 151 m² -
How the parcels are linked
Good to know
Both parcels match the address exactly.